questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Glycoprotéines
Mucoprotéines
Mucines
Mucines : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mucines : Questions médicales les plus fréquentes",
"headline": "Mucines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mucines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-13",
"dateModified": "2025-03-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mucines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mucoprotéines",
"url": "https://questionsmedicales.fr/mesh/D009088",
"about": {
"@type": "MedicalCondition",
"name": "Mucoprotéines",
"code": {
"@type": "MedicalCode",
"code": "D009088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.395.560"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mucines gastriques",
"alternateName": "Gastric Mucins",
"url": "https://questionsmedicales.fr/mesh/D005752",
"about": {
"@type": "MedicalCondition",
"name": "Mucines gastriques",
"code": {
"@type": "MedicalCode",
"code": "D005752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.395.560.631.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mucine-5AC",
"alternateName": "Mucin 5AC",
"url": "https://questionsmedicales.fr/mesh/D055271",
"about": {
"@type": "MedicalCondition",
"name": "Mucine-5AC",
"code": {
"@type": "MedicalCode",
"code": "D055271",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.395.560.631.100.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mucine-6",
"alternateName": "Mucin-6",
"url": "https://questionsmedicales.fr/mesh/D055272",
"about": {
"@type": "MedicalCondition",
"name": "Mucine-6",
"code": {
"@type": "MedicalCode",
"code": "D055272",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.395.560.631.100.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Mucine-2",
"alternateName": "Mucin-2",
"url": "https://questionsmedicales.fr/mesh/D055262",
"about": {
"@type": "MedicalCondition",
"name": "Mucine-2",
"code": {
"@type": "MedicalCode",
"code": "D055262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.395.560.631.161"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sialomucines",
"alternateName": "Sialomucins",
"url": "https://questionsmedicales.fr/mesh/D052116",
"about": {
"@type": "MedicalCondition",
"name": "Sialomucines",
"code": {
"@type": "MedicalCode",
"code": "D052116",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.395.560.631.650"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Mucines",
"alternateName": "Mucins",
"code": {
"@type": "MedicalCode",
"code": "D009077",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sara K Lindén",
"url": "https://questionsmedicales.fr/author/Sara%20K%20Lind%C3%A9n",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine."
}
},
{
"@type": "Person",
"name": "Henrik Sundh",
"url": "https://questionsmedicales.fr/author/Henrik%20Sundh",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological and Environmental Sciences, University of Gothenburg, 405 30, Gothenburg, Sweden."
}
},
{
"@type": "Person",
"name": "John Benktander",
"url": "https://questionsmedicales.fr/author/John%20Benktander",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine."
}
},
{
"@type": "Person",
"name": "Kristina Sundell",
"url": "https://questionsmedicales.fr/author/Kristina%20Sundell",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological and Environmental Sciences, University of Gothenburg, 405 30, Gothenburg, Sweden."
}
},
{
"@type": "Person",
"name": "Jessica R Kramer",
"url": "https://questionsmedicales.fr/author/Jessica%20R%20Kramer",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah 84112, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Combined Bile Duct Ablation and Fistulous Tract Embolization Using N-Butyl Cyanoacrylate to Manage a Biliary-Cutaneous Fistula Following Percutaneous Transhepatic Biliary Drainage (PTBD) for Hilar Cholangiocarcinoma.",
"datePublished": "2023-03-15",
"url": "https://questionsmedicales.fr/article/37362361",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1764294"
}
},
{
"@type": "ScholarlyArticle",
"name": "Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with serum markers in at-risk patients with hepatitis B virus.",
"datePublished": "2023-09-05",
"url": "https://questionsmedicales.fr/article/37869332",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.21037/qims-23-396"
}
},
{
"@type": "ScholarlyArticle",
"name": "Safety and efficacy of biliary stenting combined with iodine-125 seed strand followed by hepatic artery infusion chemotherapy plus lenvatinib with PD-1 inhibitor for the treatment of extrahepatic cholangiocarcinoma with malignant obstructive jaundice.",
"datePublished": "2024-01-15",
"url": "https://questionsmedicales.fr/article/38288113",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1286771"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Human Placental Amniotic Membrane Mesenchymal-Stromal-Cell-Derived Conditioned Medium Inhibits Growth and Promotes Apoptosis of Human Cholangiocarcinoma Cells In Vitro and In Vivo by Suppressing IL-6/JAK2/STAT3 Signaling.",
"datePublished": "2023-12-07",
"url": "https://questionsmedicales.fr/article/38132108",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells12242788"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial.",
"datePublished": "2024-06-10",
"url": "https://questionsmedicales.fr/article/38870977",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/S2468-1253(24)00119-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Glycoprotéines",
"item": "https://questionsmedicales.fr/mesh/D006023"
},
{
"@type": "ListItem",
"position": 5,
"name": "Mucoprotéines",
"item": "https://questionsmedicales.fr/mesh/D009088"
},
{
"@type": "ListItem",
"position": 6,
"name": "Mucines",
"item": "https://questionsmedicales.fr/mesh/D009077"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mucines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mucines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mucines",
"description": "Comment diagnostiquer une anomalie des mucines ?\nQuels examens sont utilisés pour évaluer les mucines ?\nLes tests génétiques sont-ils utiles pour les mucines ?\nQuels symptômes peuvent indiquer un problème de mucines ?\nPeut-on mesurer les niveaux de mucines dans le sang ?",
"url": "https://questionsmedicales.fr/mesh/D009077?mesh_terms=Cholangiocarcinoma&page=207#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mucines",
"description": "Quels sont les symptômes d'une carence en mucines ?\nLes mucines affectent-elles la digestion ?\nComment les mucines influencent-elles la respiration ?\nLes mucines peuvent-elles causer des allergies ?\nQuels signes indiquent une inflammation liée aux mucines ?",
"url": "https://questionsmedicales.fr/mesh/D009077?mesh_terms=Cholangiocarcinoma&page=207#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mucines",
"description": "Comment prévenir les troubles liés aux mucines ?\nLes soins oculaires réguliers aident-ils les mucines ?\nL'hygiène buccale influence-t-elle les mucines ?\nLes allergies peuvent-elles être prévenues pour protéger les mucines ?\nLe tabagisme affecte-t-il la santé des mucines ?",
"url": "https://questionsmedicales.fr/mesh/D009077?mesh_terms=Cholangiocarcinoma&page=207#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mucines",
"description": "Quels traitements existent pour les troubles des mucines ?\nLes mucines peuvent-elles être remplacées par des médicaments ?\nY a-t-il des thérapies naturelles pour les mucines ?\nLes interventions chirurgicales sont-elles nécessaires pour les mucines ?\nComment les changements alimentaires affectent-ils les mucines ?",
"url": "https://questionsmedicales.fr/mesh/D009077?mesh_terms=Cholangiocarcinoma&page=207#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mucines",
"description": "Quelles complications peuvent survenir avec des mucines anormales ?\nLes mucines anormales peuvent-elles causer des cancers ?\nComment les mucines affectent-elles la qualité de vie ?\nLes complications respiratoires sont-elles liées aux mucines ?\nLes troubles des mucines peuvent-ils affecter la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D009077?mesh_terms=Cholangiocarcinoma&page=207#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mucines",
"description": "Quels facteurs augmentent le risque de troubles des mucines ?\nLe stress influence-t-il la santé des mucines ?\nLes infections fréquentes sont-elles un facteur de risque ?\nL'alimentation joue-t-elle un rôle dans la santé des mucines ?\nLes antécédents familiaux influencent-ils les troubles des mucines ?",
"url": "https://questionsmedicales.fr/mesh/D009077?mesh_terms=Cholangiocarcinoma&page=207#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des mucines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de laboratoire et des biopsies peuvent être utilisés pour évaluer les mucines."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les mucines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunohistochimie et l'électrophorèse des protéines sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les mucines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à identifier des mutations liées à des troubles des mucines."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème de mucines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la sécheresse des muqueuses ou des infections fréquentes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer les niveaux de mucines dans le sang ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent évaluer les niveaux de mucines dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en mucines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent sécheresse des yeux, de la bouche et des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Les mucines affectent-elles la digestion ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une production insuffisante de mucines peut entraîner des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Comment les mucines influencent-elles la respiration ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles protègent les voies respiratoires et aident à piéger les particules étrangères."
}
},
{
"@type": "Question",
"name": "Les mucines peuvent-elles causer des allergies ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surproduction de mucines peut contribuer à des réactions allergiques dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une inflammation liée aux mucines ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, gonflement et douleur dans les zones affectées peuvent être des signes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux mucines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hydratation et éviter les irritants environnementaux sont essentiels."
}
},
{
"@type": "Question",
"name": "Les soins oculaires réguliers aident-ils les mucines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens oculaires réguliers peuvent prévenir les problèmes liés aux mucines oculaires."
}
},
{
"@type": "Question",
"name": "L'hygiène buccale influence-t-elle les mucines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène buccale peut prévenir les infections et maintenir la santé des mucines."
}
},
{
"@type": "Question",
"name": "Les allergies peuvent-elles être prévenues pour protéger les mucines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les allergènes connus peut réduire le risque d'inflammation des mucines."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il la santé des mucines ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut endommager les mucines et aggraver les problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les troubles des mucines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des substituts de larmes et des médicaments anti-inflammatoires."
}
},
{
"@type": "Question",
"name": "Les mucines peuvent-elles être remplacées par des médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent aider à augmenter la production de mucines dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies naturelles pour les mucines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies comme l'hydratation et les huiles essentielles peuvent aider."
}
},
{
"@type": "Question",
"name": "Les interventions chirurgicales sont-elles nécessaires pour les mucines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, des interventions chirurgicales peuvent être nécessaires pour corriger des anomalies."
}
},
{
"@type": "Question",
"name": "Comment les changements alimentaires affectent-ils les mucines ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en oméga-3 et en antioxydants peut améliorer la santé des mucines."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des mucines anormales ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections chroniques et des inflammations peuvent être des complications fréquentes."
}
},
{
"@type": "Question",
"name": "Les mucines anormales peuvent-elles causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies des mucines sont associées à un risque accru de cancers spécifiques."
}
},
{
"@type": "Question",
"name": "Comment les mucines affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles des mucines peuvent entraîner une gêne et des limitations fonctionnelles."
}
},
{
"@type": "Question",
"name": "Les complications respiratoires sont-elles liées aux mucines ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une production insuffisante de mucines peut entraîner des complications respiratoires."
}
},
{
"@type": "Question",
"name": "Les troubles des mucines peuvent-ils affecter la fertilité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines conditions liées aux mucines peuvent avoir un impact sur la fertilité masculine et féminine."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de troubles des mucines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, les maladies auto-immunes et l'exposition à des irritants sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la santé des mucines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la production et la fonction des mucines."
}
},
{
"@type": "Question",
"name": "Les infections fréquentes sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections répétées peuvent altérer la production normale de mucines."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la santé des mucines ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation déséquilibrée peut augmenter le risque de troubles des mucines."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils les troubles des mucines ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies liées aux mucines peuvent augmenter le risque."
}
}
]
}
]
}
Biliary fistula and bile leak are known complications following hepatobiliary surgery, trauma, and percutaneous biliary interventions. In the case of an isolated biliary system with a prolonged indwel...
The precise differentiation of intrahepatic cholangiocarcinoma (ICC) from atypical hepatocellular carcinoma (HCC) is vital for treatment strategy and prognostic prediction. In clinical practice, nearl...
This study enrolled 129 patients with pathologically proven mass-forming ICCs (n=53) and atypical HCCs (n=76) who had undergone preoperative Gd-EOB-DTPA contrast-enhanced MRI. The clinical data and im...
Univariate logistic regression analysis revealed normal alpha fetoprotein (AFP), elevated carbohydrate antigen 19-9 (CA19-9) level, elevated carcinoma embryonic antigen (CEA) level, central hyperinten...
A diagnostic regimen integrating tumor markers (AFP, CA19-9) and imaging biomarkers (targetoid restriction on DWI and/or targetoid sign on HBP) using Gd-EOB-DTPA-enhanced MRI could help to differentia...
Mass-forming intrahepatic cholangiocarcinoma (mass-forming ICC); atypical hepatocellular carcinoma (atypical HCC); magnetic resonance imaging (MRI); gadolinium ethoxybenzyl diethylenetriamine pentaace...
To evaluate the efficacy and safety of biliary stenting implantation with iodine-125 seed strand (SI) followed by hepatic artery infusion chemotherapy (HAIC) plus lenvatinib (Len) with programmed deat...
In this single-center retrospective study, the data of ECC patients with MOJ from March 2015 to January 2023 was assessed. Using probability score matching (PSM), the selection bias of patients was re...
A total of 104 patients were enrolled finally, including 52 patients treated with interventional therapy (SI+HAIC) plus Len with PD-1 inhibitor (SI+HAIC+Len+P group) and 52 patients treated with inter...
Interventional therapy (SI+HAIC) plus Len with PD-1 inhibitor was effective for ECC patients accompanied by MOJ with a manageable safety profile....
Mesenchymal stromal cells (MSCs) have recently been shown to play an important role in the growth and progression of many solid tumors, including cholangiocarcinoma (CCA). The human placental amniotic...
There is an unmet need for effective therapies in pretreated advanced biliary tract cancer. We aimed to evaluate the efficacy of nanoliposomal irinotecan and fluorouracil plus leucovorin compared with...
NALIRICC was a multicentre, open-label, randomised, phase 2 trial done in 17 German centres for patients aged 18 years or older, with an Eastern Cooperative Oncology Group performance status of 0-1, m...
Between Dec 4, 2017, and Aug 2, 2021, 49 patients were randomly assigned to the nanoliposomal irinotecan group and 51 patients to the control group. Median age was 65 years (IQR 59-71); 45 (45%) of 10...
The addition of nanoliposomal irinotecan to fluorouracil plus leucovorin did not improve progression-free survival or overall survival and was associated with higher toxicity compared with fluorouraci...
Servier and AIO-Studien....
In December 2022, the Taiwan National Health Insurance Administration (NHIA) announced the reimbursement of three dosages of pemigatinib 4.5 mg, 9 mg, and 13.5 mg for treating advanced intrahepatic ch...
This study used a 3-state partitioned survival model to analyze the 5 year cost-effectiveness of pemigatinib as a second-line treatment for advanced ICC patients in whom first-line gemcitabine-based c...
Pemigatinib was not cost-effective compared to mFOLFOX or 5-FU in the base-case analysis. When the price of pemigatinib was reduced by 50% or more, pemigatinib gained a positive net monetary benefit (...
According to the NCCN guidelines, the daily use of pemigatinib 13.5 mg at the hypothesized NHIA price of NT$17,820/13.5 mg was not cost-effective compared to mFOLFOX or 5-FU. The price reduction scena...
The specific growth rate of the perioperative carbohydrate antigen 19-9 values was not related to the prognosis of extrahepatic cholangiocarcinoma....